PT - JOURNAL ARTICLE AU - Pipolo, Carlotta AU - Bulfamante, Antonio Mario AU - Schillaci, Andrea AU - Banchetti, Jacopo AU - Castellani, Luca AU - Saibene, Alberto Maria AU - Felisati, Giovanni AU - Quadrio, Maurizio TI - Through The Back Door: Expiratory Accumulation Of SARS-Cov-2 In The Olfactory Mucosa As Mechanism For CNS Penetration AID - 10.1101/2020.12.09.20242396 DP - 2021 Jan 01 TA - medRxiv PG - 2020.12.09.20242396 4099 - http://medrxiv.org/content/early/2021/01/04/2020.12.09.20242396.short 4100 - http://medrxiv.org/content/early/2021/01/04/2020.12.09.20242396.full AB - Introduction SARS-CoV-2 is a respiratory virus supposed to enter the organism through aerosol or fomite transmission to the nose, eyes and oropharynx. It is responsible for various clinical symptoms, including hyposmia and other neurological ones. Current literature suggests the olfactory mucosa as a port of entry to the CNS, but how the virus reaches the olfactory groove is still unknown. Because the first neurological symptoms of invasion (hyposmia) do not correspond to first signs of infection, the hypothesis of direct contact through airborne droplets during primary infection and therefore during inspiration is not plausible. The aim of this study is to evaluate if a secondary spread to the olfactory groove in a retrograde manner during expiration could be more probable.Methods Four three-dimensional virtual models were obtained from actual CT scans and used to simulate expiratory droplets. The volume mesh consists of 25 million of cells, the simulated condition is a steady expiration, driving a flow rate of 270 ml/s, for a duration of 0.6 seconds. The droplet diameter is of 5 μm.Results The analysis of the simulations shows the virus to have a high probability to be deployed in the rhinopharynx, on the tail of medium and upper turbinates. The possibility for droplets to access the olfactory mucosa during the expiratory phase is lower than other nasal areas, but consistent.Discussion The data obtained from these simulations demonstrates the virus can be deployed in the olfactory groove during expiration. Even if the total amount in a single act is scarce, it must be considered it is repeated tens of thousands of times a day, and the source of contamination continuously acts on a timescale of several days. The present results also imply CNS penetration of SARS-CoV-2 through olfactory mucosa might be considered a complication and, consequently, prevention strategies should be considered in diseased patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe charitable trust Istituto Farmacologico "Filippo Serpero Foundation" provided partial financial support to our group by co-financing the research projectAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The clinical IRB of the s.Paolo University Hospital has granted exemption due to the nature of this restrospective studyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesResults are available on requestSARS-CoV-2severe acute respiratory syndrome coronavirus 2CTcomputed tomographyCNSCentral nervous systemLESLarge eddy simulationCFDComputational fluid dynamicsACE-2Angiotensin converting enzymeCOVID-19Coronavirus disease 2019